The concurrent use of
carbamazepine and
efavirenz leads to a modest reduction in the
plasma levels of both drugs; similar effects are predicted to occur with
phenobarbital (and therefore primidone).
The manufacturers say that when
efavirenz is given with
phenobarbital, there is a potential for reduction or increase in the
plasma levels of each drug: they therefore recommend periodic monitoring of
plasma levels.